nivolumab,batiraxcept,belzutifan,cdactin,ipilimumab
osel,miyarisan,merck,aravive,bms
['kcsm,(-skcsm)', '/ipi', 'nivo', 'rcc,(-irccs),(-srcc),(-urcc)', 'batiraxcept', 'cbm588', 'belzutifan']
#asco22 poster discussions: 1) phi litespark-001 #hif-2a inh belzutifan 41 mo f/u orr 25% in pre-io and vegf-tx #ccrcc, 2) phib/ii axl recomb fusion protein batiraxcept + cabo 60 orr 42% after &gt;1l tx in adv #kcsm, 3) change in abx res genes predict benefit to cbm588 + nivo/ipi 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope